Biotech

Breaking news and analysis on the biotech industry — covering drug development, clinical trials, IPOs, M&A, and the companies pushing biopharma forward.

brain
Biotech

Merck halts ph. 2 Alzheimer’s trial after underwhelming efficacy

Merck stopped the study after the small molecule MK-1167 “did not meet the necessary efficacy criteria to warrant further investigation."
Darren Incorvaia Jul 1, 2026 2:35pm
two jiggsaw puzzles connected with drawn hands shaking on the two puzzles

Zimmer Biomet buys pain relief system from Pacira in $140M deal

Jul 1, 2026 10:58am
Puerto Rico makes its case as a biotech manufacturing hub

Puerto Rico makes its case as a biotech manufacturing hub

Brought to you by Invest Puerto Rico
Layoffs

Pressure of biopharma layoffs continues to ease in Q2'26

Jul 1, 2026 10:30am
How AI is reshaping biopharma decision-making

How AI is reshaping biopharma decision-making

Brought to you by Clarivate
Deal

Ipsen pens €700M deal to buy Swiss biotech for rare disease drug

Jul 1, 2026 8:05am